Uncategorized
Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at three upcoming investor conferences: 2017 BIO CEO & Investor ConferenceMonday, February 13, 2017 at 8:30 a.m. Eastern TimeThe Waldorf Astoria New York, New York, NY 2017 RBC Capital Markets Global Healthcare ConferenceThursday, February 23,